Piper Sandler Issues Pessimistic Forecast for CVS Health (NYSE:CVS) Stock Price

CVS Health (NYSE:CVS) had its target price dropped by Piper Sandler from $101.00 to $99.00 in a report issued on Tuesday,Benzinga reports. The firm presently has an “overweight” rating on the pharmacy operator’s stock. Piper Sandler’s target price would suggest a potential upside of 38.70% from the stock’s previous close.

A number of other brokerages have also recently weighed in on CVS. Barclays upped their price target on CVS Health from $87.00 to $93.00 and gave the company an “overweight” rating in a research report on Wednesday, December 10th. JPMorgan Chase & Co. boosted their target price on shares of CVS Health from $93.00 to $101.00 and gave the company an “overweight” rating in a research note on Wednesday, December 17th. Bank of America lowered their target price on shares of CVS Health from $100.00 to $95.00 and set a “buy” rating on the stock in a report on Tuesday, January 27th. UBS Group restated an “outperform” rating on shares of CVS Health in a research report on Wednesday, December 10th. Finally, TD Cowen reaffirmed a “buy” rating on shares of CVS Health in a research note on Friday, March 13th. Twenty analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, CVS Health has a consensus rating of “Moderate Buy” and an average price target of $94.95.

CVS Health Stock Performance

CVS traded up $1.24 during trading on Tuesday, reaching $71.38. 1,390,316 shares of the company’s stock were exchanged, compared to its average volume of 8,771,730. The company has a market capitalization of $90.80 billion, a P/E ratio of 51.71, a PEG ratio of 0.73 and a beta of 0.49. The company has a quick ratio of 0.63, a current ratio of 0.84 and a debt-to-equity ratio of 0.80. The business has a 50 day moving average price of $76.45 and a 200 day moving average price of $77.76. CVS Health has a fifty-two week low of $58.35 and a fifty-two week high of $85.15.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Tuesday, February 10th. The pharmacy operator reported $1.09 EPS for the quarter, topping analysts’ consensus estimates of $1.00 by $0.09. CVS Health had a net margin of 0.44% and a return on equity of 11.31%. The company had revenue of $105.69 billion during the quarter, compared to the consensus estimate of $103.67 billion. During the same period last year, the firm earned $1.19 EPS. The firm’s revenue for the quarter was up 8.2% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. As a group, analysts predict that CVS Health will post 5.89 earnings per share for the current fiscal year.

Institutional Trading of CVS Health

Several institutional investors and hedge funds have recently made changes to their positions in CVS. Harbor Capital Advisors Inc. grew its position in shares of CVS Health by 72.1% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock worth $26,000 after buying an additional 142 shares during the period. Caitong International Asset Management Co. Ltd raised its position in shares of CVS Health by 407.2% in the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 350 shares of the pharmacy operator’s stock valued at $26,000 after acquiring an additional 281 shares during the period. Swiss RE Ltd. bought a new position in CVS Health during the 4th quarter worth approximately $26,000. Sankala Group LLC acquired a new position in CVS Health during the fourth quarter valued at approximately $28,000. Finally, Mcguire Capital Advisors Inc. bought a new stake in CVS Health in the fourth quarter valued at approximately $28,000. Institutional investors own 80.66% of the company’s stock.

Trending Headlines about CVS Health

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: CVS plans to open roughly 60 stores in 2026 (traditional, Target-based and ~20 pharmacy-only sites) after years of net closures — a deliberate footprint reset intended to capture more pharmacy volume and improve retail margins. CVS to Grow Store Footprint This Year With 60 New Locations
• Positive Sentiment: CVS opened its first “apothecary‑style” pharmacy-only store in Chicago and plans nearly 20 similar sites focused on prescriptions and pharmacist care — a low‑capex format targeted at underserved neighborhoods that could raise pharmacy same‑store performance. CVS plans roughly 60 store openings in 2026 after years of net closures
• Positive Sentiment: CVS is cited as a leader in the growing chemotherapy‑at‑home services market — an expanding, higher‑margin care channel that supports long‑term services growth beyond retail pharmacy. Trends and Opportunities in the Chemotherapy-At-Home Services Market, 2026-2030
• Neutral Sentiment: Zacks highlights medical stocks that could beat earnings using its Earnings ESP tool — a useful signal for investors but not a direct company announcement; no specific CVS beat claim in the item. These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
• Neutral Sentiment: Local regulatory changes (e.g., a Tennessee reform bill) could allow some CVS pharmacies to remain open under new rules — positive operationally in specific markets but limited in overall impact. CVS could keep pharmacies open under Tennessee reform bill, local pharmacists say
• Negative Sentiment: CVS reached a proposed FTC settlement related to insulin pricing — a regulatory overhang that could involve concessions or payments and inject near‑term legal risk and headlines. Investors will watch the final terms and timing. CVS Health (CVS) Reaches Proposed FTC Settlement on Insulin Pricing

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.